Niels Skjærbæk

Director de Operaciones en Conrig Pharma ApS .

Health Technology

Perfil

Niels Skjærbæk is currently the Chief Operating Officer & Director at Conrig Pharma ApS.
Previously, he worked as the Director & Manager-Business Development at Bioneer A.

Cargos activos de Niels Skjærbæk

Empresas	Cargo	Inicio
Conrig Pharma ApS Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark.	Director de Operaciones	-

Todos los cargos activos de Niels Skjærbæk

Antiguos cargos conocidos de Niels Skjærbæk.

Empresas	Cargo	Fin
Bioneer A/S Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Niels Skjærbæk.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Niels Skjærbæk.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Bioneer A/S Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.	Health Technology
Conrig Pharma ApS Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark.	Health Technology